Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-06

Clinical Trial Update: Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions [Phase 4]

View source ↗

Summary

Phase 4 trial investigating adjusted dosing of heparin and protamine and its relationship with postoperative bleeding and transfusion requirements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)
  • Protamine sulfate (protamine sulfate)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Cardiac Surgery, Bleeding | Phase 4 | Status: UNKNOWN